Kairos Pharma Ltd (AMEX: KAPA) Is Under Pressure Due To Weak Fundamental Momentum.
In the last trading session, 3.95 million Kairos Pharma Ltd (AMEX:KAPA) shares changed hands as the company’s beta touched 0. With the company’s per share
In the last trading session, 3.95 million Kairos Pharma Ltd (AMEX:KAPA) shares changed hands as the company’s beta touched 0. With the company’s per share
Kairos Pharma Ltd (AMEX:KAPA) has seen 241.3 million shares traded in the last trading session. The company, currently valued at $19.71M, closed the last trade
During the last session, Kairos Pharma Ltd (AMEX:KAPA)’s traded shares were 0.28 million. The 52-week high for the KAPA share is $4.00, that puts it
In the last trading session, 1.51 million Kairos Pharma Ltd (AMEX:KAPA) shares changed hands as the company’s beta touched 0. With the company’s per share
Kairos Pharma Ltd (AMEX:KAPA) has seen 728.67 shares traded in the last trading session. The company, currently valued at $10.45M, closed the last trade at
In the last trading session, 1.3 million shares of the Kairos Pharma Ltd (AMEX:KAPA) were traded. Most recently the company’s share price was $0.57, and
Kairos Pharma Ltd (AMEX:KAPA)’s traded shares stood at 1.84 million during the last session. At the close of trading, the stock’s price was $0.57, to
In the last trading session, 8.43 million Kairos Pharma Ltd (AMEX:KAPA) shares changed hands as the company’s beta touched 0. With the company’s per share
In last trading session, Kairos Pharma Ltd (AMEX:KAPA) saw 4.39 million shares changing hands with its beta currently measuring 0. Company’s recent per share price
© 2024, Powered by Smart TechOne